{"id":"apx005m","safety":{"commonSideEffects":[{"effect":"Fatigue","drugRate":"75.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":76,"totalAffected":57,"trialsReporting":5},{"effect":"Nausea","drugRate":"68.4%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":76,"totalAffected":52,"trialsReporting":5},{"effect":"Aspartate aminotransferase increased","drugRate":"48.7%","organSystem":"Investigations","placeboRate":"","totalAtRisk":76,"totalAffected":37,"trialsReporting":5},{"effect":"Constipation","drugRate":"44.7%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":76,"totalAffected":34,"trialsReporting":5},{"effect":"Diarrhoea","drugRate":"47.2%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":72,"totalAffected":34,"trialsReporting":3},{"effect":"Alanine aminotransferase increased","drugRate":"42.7%","organSystem":"Investigations","placeboRate":"","totalAtRisk":75,"totalAffected":32,"trialsReporting":4},{"effect":"Anaemia","drugRate":"43.1%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":72,"totalAffected":31,"trialsReporting":3},{"effect":"Decreased appetite","drugRate":"43.1%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":72,"totalAffected":31,"trialsReporting":3},{"effect":"Vomiting","drugRate":"38.2%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":76,"totalAffected":29,"trialsReporting":5},{"effect":"Pyrexia","drugRate":"33.3%","organSystem":"General disorders","placeboRate":"","totalAtRisk":72,"totalAffected":24,"trialsReporting":3},{"effect":"Thrombocytopenia","drugRate":"34.8%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":69,"totalAffected":24,"trialsReporting":2},{"effect":"Chills","drugRate":"28.9%","organSystem":"General disorders","placeboRate":"","totalAtRisk":76,"totalAffected":22,"trialsReporting":5},{"effect":"Cough","drugRate":"28.9%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":76,"totalAffected":22,"trialsReporting":5},{"effect":"Neutropenia","drugRate":"31.9%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":69,"totalAffected":22,"trialsReporting":2},{"effect":"Rash","drugRate":"29.2%","organSystem":"Skin and subcutaneous tissue disorders","placeboRate":"","totalAtRisk":72,"totalAffected":21,"trialsReporting":3},{"effect":"Abdominal pain","drugRate":"25.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":76,"totalAffected":19,"trialsReporting":5},{"effect":"Dyspnoea","drugRate":"26.4%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":72,"totalAffected":19,"trialsReporting":3},{"effect":"Headache","drugRate":"23.7%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":76,"totalAffected":18,"trialsReporting":5},{"effect":"Alopecia","drugRate":"26.1%","organSystem":"Skin and subcutaneous tissue disorders","placeboRate":"","totalAtRisk":69,"totalAffected":18,"trialsReporting":2},{"effect":"Dehydration","drugRate":"22.7%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":75,"totalAffected":17,"trialsReporting":4},{"effect":"Oedema peripheral","drugRate":"38.5%","organSystem":"General disorders","placeboRate":"","totalAtRisk":39,"totalAffected":15,"trialsReporting":2},{"effect":"Blood alkaline phosphatase increased","drugRate":"20.8%","organSystem":"Investigations","placeboRate":"","totalAtRisk":72,"totalAffected":15,"trialsReporting":3},{"effect":"Weight decreased","drugRate":"20.8%","organSystem":"Investigations","placeboRate":"","totalAtRisk":72,"totalAffected":15,"trialsReporting":3},{"effect":"Hypotension","drugRate":"19.7%","organSystem":"Vascular disorders","placeboRate":"","totalAtRisk":76,"totalAffected":15,"trialsReporting":5},{"effect":"Hyponatraemia","drugRate":"19.4%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":72,"totalAffected":14,"trialsReporting":3},{"effect":"Leukopenia","drugRate":"20.3%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":69,"totalAffected":14,"trialsReporting":2},{"effect":"Platelet count decreased","drugRate":"30.2%","organSystem":"Investigations","placeboRate":"","totalAtRisk":43,"totalAffected":13,"trialsReporting":4},{"effect":"Neutrophil count decreased","drugRate":"35.1%","organSystem":"Investigations","placeboRate":"","totalAtRisk":37,"totalAffected":13,"trialsReporting":2},{"effect":"Epistaxis","drugRate":"16.7%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":72,"totalAffected":12,"trialsReporting":3},{"effect":"Pruritus","drugRate":"15.8%","organSystem":"Skin and subcutaneous tissue disorders","placeboRate":"","totalAtRisk":76,"totalAffected":12,"trialsReporting":5},{"effect":"Neuropathy peripheral","drugRate":"17.4%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":69,"totalAffected":12,"trialsReporting":2},{"effect":"Dysphagia","drugRate":"28.2%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":39,"totalAffected":11,"trialsReporting":3},{"effect":"Hypokalaemia","drugRate":"15.3%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":72,"totalAffected":11,"trialsReporting":3},{"effect":"Arthralgia","drugRate":"14.5%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":76,"totalAffected":11,"trialsReporting":5},{"effect":"Back pain","drugRate":"14.5%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":76,"totalAffected":11,"trialsReporting":5},{"effect":"Anxiety","drugRate":"23.3%","organSystem":"Psychiatric disorders","placeboRate":"","totalAtRisk":43,"totalAffected":10,"trialsReporting":4},{"effect":"Peripheral sensory neuropathy","drugRate":"13.7%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":73,"totalAffected":10,"trialsReporting":4},{"effect":"White blood cell count decreased","drugRate":"27.8%","organSystem":"Investigations","placeboRate":"","totalAtRisk":36,"totalAffected":10,"trialsReporting":1},{"effect":"Abdominal pain upper","drugRate":"12.5%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":72,"totalAffected":9,"trialsReporting":3},{"effect":"Infusion related reaction","drugRate":"11.5%","organSystem":"Injury, poisoning and procedural complications","placeboRate":"","totalAtRisk":78,"totalAffected":9,"trialsReporting":5},{"effect":"Dizziness","drugRate":"11.8%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":76,"totalAffected":9,"trialsReporting":5},{"effect":"Oesophagitis","drugRate":"27.3%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":33,"totalAffected":9,"trialsReporting":1},{"effect":"Cytokine release syndrome","drugRate":"10.7%","organSystem":"Immune system disorders","placeboRate":"","totalAtRisk":75,"totalAffected":8,"trialsReporting":4},{"effect":"Myalgia","drugRate":"10.7%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":75,"totalAffected":8,"trialsReporting":4},{"effect":"Blood bilirubin increased","drugRate":"16.3%","organSystem":"Investigations","placeboRate":"","totalAtRisk":43,"totalAffected":7,"trialsReporting":4},{"effect":"Hyperglycaemia","drugRate":"9.7%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":72,"totalAffected":7,"trialsReporting":3},{"effect":"Insomnia","drugRate":"16.3%","organSystem":"Psychiatric disorders","placeboRate":"","totalAtRisk":43,"totalAffected":7,"trialsReporting":4},{"effect":"Hypoalbuminaemia","drugRate":"19.4%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":36,"totalAffected":7,"trialsReporting":1},{"effect":"Oesophageal pain","drugRate":"21.2%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":33,"totalAffected":7,"trialsReporting":1},{"effect":"Dyspepsia","drugRate":"8.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":75,"totalAffected":6,"trialsReporting":4}],"seriousAdverseEvents":[{"event":"Oesophagitis","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"9.1%"},{"event":"Vomiting","detail":"Gastrointestinal disorders. 2 trial(s).","severity":"serious","incidence":"7.2%"},{"event":"Dehydration","detail":"Metabolism and nutrition disorders. 2 trial(s).","severity":"serious","incidence":"5.8%"},{"event":"Nausea","detail":"Gastrointestinal disorders. 2 trial(s).","severity":"serious","incidence":"5.8%"},{"event":"Cardiac failure","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"5.6%"},{"event":"Enterocolitis","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"5.6%"},{"event":"Thrombotic microangiopathy","detail":"Blood and lymphatic system disorders. 1 trial(s).","severity":"serious","incidence":"5.6%"},{"event":"Pyrexia","detail":"General disorders. 2 trial(s).","severity":"serious","incidence":"5.1%"},{"event":"Respiratory failure","detail":"Respiratory, thoracic and mediastinal disorders. 2 trial(s).","severity":"serious","incidence":"5.1%"},{"event":"Cytokine release syndrome","detail":"Immune system disorders. 3 trial(s).","severity":"serious","incidence":"4.2%"},{"event":"Stroke","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"33.3%"},{"event":"Dysphagia","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"3.0%"},{"event":"Pneumatosis intestinalis","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"3.0%"},{"event":"Guillain-Barre syndrome","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"3.0%"},{"event":"Impaired healing","detail":"General disorders. 1 trial(s).","severity":"serious","incidence":"3.0%"},{"event":"Chylothorax","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"3.0%"},{"event":"Pneumonia aspiration","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"3.0%"},{"event":"Endometrial cancer","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"3.0%"},{"event":"Pneumonia","detail":"Infections and infestations. 3 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Seizure","detail":"Nervous system disorders. 2 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Ascites","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Demyelinating polyneuropathy","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Diplopia","detail":"Eye disorders. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Duodenal obstruction","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Haemoptysis","detail":"Vascular disorders. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"IIIrd nerve disorder","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Immune-mediated pneumonitis","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Liver abscess","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Neutropenic sepsis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"2.8%"},{"event":"Pneumonia staphylococcal","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"2.8%"}]},"_chembl":{"chemblId":"CHEMBL4297888","moleculeType":"Antibody"},"_sources":{"safety.commonSideEffects":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (5 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-20T11:09:57.675504+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T02:28:51.035Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":3,"lastValidatedAt":"2026-04-20T11:10:04.582273+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT05419479","phase":"PHASE1, PHASE2","title":"Switch Maintenance in Pancreatic","status":"SUSPENDED","sponsor":"James Cleary, MD, PhD","startDate":"2022-11-30","conditions":"Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas","enrollment":46},{"nctId":"NCT03389802","phase":"PHASE1","title":"Phase I Study of APX005M in Pediatric Central Nervous System Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2018-03-01","conditions":"Glioblastoma Multiforme, High-grade Astrocytoma Not Otherwise Specified (NOS), CNS Primary Tumor, Not Otherwise Specified (NOS)","enrollment":32},{"nctId":"NCT02600949","phase":"PHASE1","title":"Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-05-11","conditions":"Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7","enrollment":117},{"nctId":"NCT04130854","phase":"PHASE2","title":"INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2020-04-24","conditions":"Locally Advanced Rectal Adenocarcinoma","enrollment":58},{"nctId":"NCT02706353","phase":"PHASE1, PHASE2","title":"APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-06-02","conditions":"Melanoma","enrollment":34},{"nctId":"NCT04495257","phase":"PHASE1","title":"A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2020-09-14","conditions":"Advanced Melanoma, Renal Cell Carcinoma","enrollment":26},{"nctId":"NCT03719430","phase":"PHASE2","title":"APX005M and Doxorubicin in Advanced Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexander Z. Wei, MD","startDate":"2019-03-20","conditions":"Soft Tissue Sarcoma","enrollment":27},{"nctId":"NCT03502330","phase":"PHASE1","title":"APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma","status":"COMPLETED","sponsor":"Yale University","startDate":"2018-06-09","conditions":"Advanced Melanoma, Non-small Cell Lung Cancer, Renal Cell Carcinoma","enrollment":42},{"nctId":"NCT03165994","phase":"PHASE2","title":"APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers","status":"COMPLETED","sponsor":"Apexigen America, Inc.","startDate":"2017-10-06","conditions":"Esophageal Cancer, GastroEsophageal Cancer","enrollment":34},{"nctId":"NCT04337931","phase":"PHASE2","title":"A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma","status":"TERMINATED","sponsor":"Apexigen America, Inc.","startDate":"2019-06-12","conditions":"Unresectable Melanoma, Metastatic Melanoma, Cancer","enrollment":45},{"nctId":"NCT03123783","phase":"PHASE1, PHASE2","title":"CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab","status":"COMPLETED","sponsor":"Apexigen America, Inc.","startDate":"2017-07-10","conditions":"Cancer, Non Small Cell Lung Cancer Metastatic, Metastatic Melanoma","enrollment":140},{"nctId":"NCT02482168","phase":"PHASE1","title":"Study of the CD40 Agonistic Monoclonal Antibody APX005M","status":"COMPLETED","sponsor":"Apexigen America, Inc.","startDate":"2015-05","conditions":"Cancer, NSCLC, Melanoma","enrollment":43},{"nctId":"NCT05201001","phase":"PHASE2","title":"APX005M in Patients With Recurrent Ovarian Cancer","status":"WITHDRAWN","sponsor":"Nordic Society of Gynaecological Oncology - Clinical Trials Unit","startDate":"2023-09-07","conditions":"Ovarian Cancer","enrollment":""},{"nctId":"NCT03214250","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma","status":"COMPLETED","sponsor":"Parker Institute for Cancer Immunotherapy","startDate":"2017-07-21","conditions":"Metastatic Pancreatic Adenocarcinoma","enrollment":129},{"nctId":"NCT03597282","phase":"PHASE1","title":"A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma","status":"TERMINATED","sponsor":"BioNTech US Inc.","startDate":"2018-10-08","conditions":"Metastatic Melanoma","enrollment":22}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"ACUTE CORONARY SYNDROME"},{"count":3,"reaction":"ACUTE KIDNEY INJURY"},{"count":3,"reaction":"DEATH"},{"count":3,"reaction":"FEBRILE NEUTROPENIA"},{"count":3,"reaction":"PNEUMONIA"},{"count":2,"reaction":"ATRIAL FIBRILLATION"},{"count":2,"reaction":"CEREBRAL INFARCTION"},{"count":2,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":2,"reaction":"CYTOKINE RELEASE SYNDROME"},{"count":2,"reaction":"PLEURAL EFFUSION"}],"_approvalHistory":[],"publicationCount":11,"structuredTrialResults":[{"hr":"0.577","nctId":"NCT03214250","phase":"PHASE1, PHASE2","pValue":"0.006","ciLower":"0.417","ciUpper":"","endpoint":"1-year Overall Survival Rate","enrollment":129}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CD40 Agonistic Monoclonal Antibody","PYX-107","Sotigalimab","APX-005M","CD40"],"phase":"phase_2","status":"active","brandName":"APX005M","genericName":"APX005M","companyName":"Apexigen America, Inc.","companyId":"apexigen-america-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":8,"withResults":5},"validation":{"fieldsValidated":3,"lastValidatedAt":"2026-04-20T11:10:04.582273+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}